CTI BioPharma Corp. Total Non Current Liabilities 2011-2026 | CTIC

Annual Total Non Current Liabilities CTI BioPharma Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	1.17 M	9.86 M	13.8 M	19.5 M	15.4 M	24.5 M	17.5 M	30.9 M	18.1 M	16.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
30.9 M	1.17 M	16.7 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.37	-8.67 %	$ 350 M	Britain
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Adagene ADAG	158 M	$ 1.65	6.11 %	$ 92.9 M	China
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.43	-2.69 %	$ 8.25 B	Australia
Biogen BIIB	9.03 B	$ 177.93	-4.15 %	$ 25.9 B	USA
Arrowhead Pharmaceuticals ARWR	686 M	$ 65.89	-0.06 %	$ 8.81 B	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
AstraZeneca PLC AZN	30.8 B	$ 94.4	0.82 %	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Ascendis Pharma A/S ASND	101 M	$ 214.55	2.77 %	$ 5 B	Danmark
Codiak BioSciences CDAK	119 M	-	-55.98 %	$ 2.15 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Bristol-Myers Squibb Company BMY	59.9 B	$ 55.84	0.13 %	$ 113 B	USA
Cerevel Therapeutics Holdings CERE	4.4 M	-	-	$ 7.29 B	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Caladrius Biosciences CLBS	254 K	-	-16.75 %	$ 25.8 M	USA
BioLineRx Ltd. BLRX	8.22 M	$ 2.86	-	$ 908 M	Israel
Clearside Biomedical CLSD	4.72 M	-	-	$ 25.3 M	USA
Chimerix CMRX	196 K	-	-	$ 756 M	USA
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
BioNTech SE BNTX	341 M	$ 106.88	4.6 %	$ 27.2 B	Germany
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 4.18	-1.65 %	$ 9.1 B	Israel
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Catalyst Biosciences CBIO	981 K	$ 11.09	1.0 %	$ 730 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Coherus BioSciences CHRS	189 M	$ 1.69	2.12 %	$ 159 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 28.99	-1.39 %	$ 1.4 B	USA
Celldex Therapeutics CLDX	17.3 M	$ 25.71	0.16 %	$ 1.66 M	USA
Cellectis S.A. CLLS	109 M	$ 4.24	-0.47 %	$ 116 M	France
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA